BeStock  
Markets › Compare › MLYS vs AVLN

MLYS vs AVLN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MLYS · Mineralys Therapeutics$13.66 ▼ 3.53%
AVLN · Avalyn Pharma$28.40 ▼ 1.05%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

466992115138Apr 30, '26Aug 12, '26Nov 20, '26
  • MLYS -48.7%
  • AVLN -3.7%

Head to head

MetricMLYSAVLN
Price$13.66$28.40
Change today▼ 3.53%▼ 1.05%
Market cap$1.21B$1.26B
Return, 3 months-45.9%-24.6%
Return, year to date-62.4%–
Return, 1 year-67.4%–
P/E (TTM)––
P/B2.43.4
P/E percentile vs own 5y94th74th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-55.2%-43.3%
Gross margin––
Operating margin––
Net margin––
Return on equity-68.5%-25.9%
Analyst target vs. price+233.1%+111.3%
Analyst buy share83%100%
RSI (14)2951
30-day volatility85.9%62.3%
Max drawdown, 1 year-71.1%-40.6%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AVLN is the largest of the group by market value.
  • AVLN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top